Food and Drug Policy Forum


FDLI's Food and Drug Policy Forum provides a marketplace for the exchange of policy ideas regarding food and drug law issues, and is complimentary to all FDLI Members. Policy Forum articles are on cutting-edge state, national, and international policy issues related to food and drug law.


The Policy Forum is published monthly and is available free to members. Individual issues of the Policy Forum are available for separate purchase.

Interested in becoming an author for the Food and Drug Policy Forum? Please read our Policy Forum Author Guidelines



Food and Drug Policy Forum

How Can Policymakers Bridge the Gap Between Precision Medicine and FDA Regulation?

August 2015

Food and Drug Policy Forum Volume 5, issue 7, 2015, August 19, 2015. Peter Huber and Paul Howard of the Manhattan Institute for Poli...

Reply to Professor Sugarman

June 2015

This special edition of the Food and Drug Law Institute’s Food and Drug Policy Forum features a response to an earlier article...

Finding the Right Benefit-Risk Balance in U.S. Sunscreen Regulation

June 2015

FDLI’s Food and Drug Policy Forum May 2015 issue, “Finding the Right Benefit-Risk Balance in U.S. Sunscreen Regulat...

Should Food Businesses Be Able to Use the First Amendment to Resist Providing Consumers with Government-Mandated Public Health Messages?

April 2015

Should government-mandated food labeling ever be considered unconstitutional as impermissible “compelled speech”?  Steph...

Food Fight: An Examination of Recent Trends in Food Litigation and Where We Go From Here

April 2015

This special issue of the Food and Drug Law Institute’s Food and Drug Policy Forum brings together a series of short reflections on...

The Policy Forum welcomes articles on cutting-edge state, national and international policy issues related to food and drug law. FDLI's Food and Drug Policy Forum is designed to provide a venue for the presentation of information, analysis and policy recommendations in the following areas: food, drugs, animal drugs, biologics, cosmetics, diagnostics, dietary supplements, medical devices and tobacco.

Each peer-reviewed issue of the Policy Forum presents an important policy topic in the form of a question, provides background information and detailed discussion of the issues involved in that policy question, details the relevant research, cites pertinent sources, and then makes policy recommendations.